Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Addex Therapeutics Ltd - American Depositary Shares (NQ:ADXN)

4.720 -0.570 (-10.78%)
Delayed Quote Updated: 11:06 AM EST, Nov 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Addex Therapeutics Ltd - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Addex (ADXN) Q2 2026 Earnings Call Transcript ↗
Biotech regains GABAB rights, extends cash runway into Q4 2027. 
Via The Motley Fool
Topics Earnings
Top movers in Monday's session ↗
Via Chartmill
News headline image
Earnings Scheduled For September 1, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 24, 2025 ↗
 
Via Benzinga
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
Addex Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript ↗
Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. Benzinga APIs provide... 
Via Benzinga
Topics Earnings
News headline image
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For September 30, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For June 19, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 25, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 21, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 22, 2024 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
S&P 500 Edges Higher; American Woodmark Shares Slide ↗
 
Via Benzinga
Topics Stocks
News headline image
Crude Oil Dips; Addex Therapeutics Shares Spike Higher ↗
 
Via Benzinga
News headline image
US Stocks Mixed; ScanSource Reports Weak Q4 Results ↗
 
Via Benzinga
News headline image
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder ↗
Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330 million plus royalties under the... 
Via Benzinga
News headline image
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
After Disappointing Data, Johnson & Johnson Halts Developing Epilepsy Drug Candidate ↗
Addex Therapeutics announces Janssen Pharmaceuticals, a Johnson & Johnson unit, has halted ADX71149 development for epilepsy after Phase 2 data. 
Via Benzinga
News headline image
ADXN Stock Earnings: Addex Therapeutics Reported Results for Q1 2024 ↗
Addex Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.